MJFF Assists Nitrome Biosciences’ Pursuit of Parkinson’s Therapies

MJFF Assists Nitrome Biosciences’ Pursuit of Parkinson’s Therapies
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded Nitrome Biosciences a Target Advancement grant to further the company’s development of therapies targeting Parkinson’s disease. Specifically, the grant will be used to further Nitrome’s biological studies of a new Parkinson’s drug target. The therapies are aimed at inhibiting a newly identified enzyme the company calls synuclein nitrase. The ... read more
Source: Parkinson’s News TodayPublished on 2019-06-14By Mary Chapman